At a glance
ClinicalIndex Comparison RecordN/ACompleted· 41 enrolled
Drug / intervention
Inpatient serious illness care programbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Inpatient Advance Care Planning Intervention for Older Patients With Hematologic Malignancies
In Brief
A clinical study evaluating Inpatient serious illness care program for Hematologic Malignancies. Completed, enrolled 41 participants across 1 site.
Detailed Summary
This is a pilot study to assess the preliminary efficacy of an inpatient advance care planning intervention on outcomes in older patients with hematologic malignancies
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHematologic Malignancies
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedJun 2022
Enrollment StartNov 2022
Primary CompletionAug 2024
Study CompletionNov 2024
TodayJul 2026
First PostedJun 27, 2022
Enrollment StartNov 23, 2022
Primary CompletionAug 23, 2024
Study CompletionNov 14, 2024
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 4.0 years ago
Interventions
Inpatient serious illness care programbehavioral
Inpatient advance care planning intervention that will be delivered by advanced care practitioners or hematology/oncology fellow physicians. The intervention will be an adapted version of the serious illness care program.